Oncotect Inc.
Biotechnology company · Raleigh, North Carolina, United States
Oncotect Inc. is a biotechnology company headquartered in Raleigh, North Carolina, United States. Its earliest recorded incorporation is in 2023. It has reported private securities offerings to the US SEC, most recently $125,000 sold in a notice filed in 2024.
Oncotect at a glance
What does Oncotect do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $125,000 sold (2024).
Frequently asked questions about Oncotect
Where is Oncotect headquartered?
Oncotect Inc. is headquartered in Raleigh, North Carolina, United States.
What does Oncotect do?
Oncotect Inc. is a biotechnology company.
When was Oncotect founded?
The earliest incorporation on record for Oncotect Inc. is in 2023, according to public company registers.
Similar companies
- Arrevus, Inc.Raleigh, North Carolina, United States
- NuPulseCV, Inc.Raleigh, North Carolina, United States
- GeneVentiv Therapeutics, Inc.Raleigh, North Carolina, United States
- RainBio, Inc.Raleigh, North Carolina, United States
- Aer Therapeutics, Inc.Raleigh, North Carolina, United States
- Merz Pharmaceuticals, LLCRaleigh, North Carolina, United States
- Glycan Therapeutics CorporationRaleigh, North Carolina, United States
- Tribofilm Research IncRaleigh, North Carolina, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences